[Page Banner Image]

The following is a review of diagnostics related medical research worldwide

The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.

The following information has been compiled from publicly available Sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.

[HRule Image]

Research News for September 1999

Research performed at the University of Leipzig in Germany has demonstrated that testing for the S-100B protein in blood soon after a mild head injury may spot brain damage, even when imaging scans are normal. The investigators report that S-100B levels rose along with severity of brain injury (as confirmed on CT scan). Follow-up of patient outcomes 6 months after injury suggest that S-100B levels can also predict patient recovery.
Source: Neurosurgery September 1999;45.

A new HIV testing strategy - Serologic Testing Algorithm for Recent HIV Seroconversions (STARHS)developed by the Centers for Disease Control and Prevention (CDC) allows researchers to distinguish HIV infections acquired in the last 6 months from those acquired more than 6 months ago.

Nexell Therapeutics Inc. has received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Program grant of $535,000 to develop the tumor enrichment column (TEC) into a commercial kit for the detection of breast, prostate and lung cancer micrometastases.

Diacrin in collaboration with Beth Israel Deaconess Medical Center have implanted fetal pig brain cells into the brain of a stroke patient with the hope that the fetal pig brain cells will replace the cells that have died as a result of the stroke. The therapy is part of a Phase 1 clinical trial.

The SENTRY Antimicrobial Surveillance Program, a worldwide tracking program that collects data on infectious disease pathogens has reported that bacterial resistance to antibiotic treatment -- particularly in respiratory tract infections -- in North and South America continues to mount at an alarming pace. Respiratory tract infections include bronchitis, sinusitis and pneumonia. The SENTRY Program is funded by the pharmaceutical industry, primarily through a grant from Bristol-Myers Squibb Company.

[HRule Image]

* Research News - August 1999
* Research News - July 1999
* Research News - June 1999
* Research News - May 1999
* Research News - April 1999
* Research News - March 1999
* Research News - Fabuary 1999
* Research News - January 1999
* Research News - December 1998
* Research News - November 1998
* Research News - October 1998
* Research News - September 1998
* Research News - August 1998
* Research News - July 1998
* Research News - June 1998
* Research News - May 1998
* Research News - April 1998
* Research News - March 1998
* Research News - February 1998
* Research News - January 1998
* Research News - July 1997
* Research News - June 1997
* Research News - May 1997
* Research News - April 1997
* Research News - March 1997
* Research News - February 1997
* Research News - January 1997
* Research News - December 1996
* Research News - November 1996
* Research News - October 1996
* Research News - September 1996
* Research News - August 1996
* Research News - July 1996
* Research News - June 1996

[HRule Image]

Home | Company Profile | Services | Research Reports Available
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links

[HRule Image]
Send mail to stratcom@pagebleu.com with questions or comments about this web site.

Concept and Design Blue Page Productions
Copyright 1996-1999 STRATCOM

Last modified: October 1, 1999